| Literature DB >> 35807165 |
Lars B Dahlin1,2,3, Raquel Perez4, Erika Nyman3,5, Malin Zimmerman1,2, Juan Merlo4,6.
Abstract
We aimed to study psychological health, as approximated by the use of psychotropic drugs, in a population diagnosed and surgically treated for carpal tunnel syndrome (CTS) or ulnar nerve entrapment (UNE), or both, also considering the demographic and socioeconomic factors of the individuals. Linking data from five large national registers, use of psychotropics (at least one dispensation during the first year after the surgery or the baseline date) was examined in around 5.8 million people 25-80 years old residing in Sweden 2010. Among these individuals, 9728 (0.17%), 890 (0.02%) and 149 (0.00%) were identified as diagnosed and surgically treated for CTS, UNE, or both, respectively. As much as 28%, 34% and 36% in each group, respectively, used psychotropic drugs, compared with 19% in the general population. Regression analyses showed a general higher risk for use of psychotropics related to these nerve compression disorders, to higher age, being a woman, and having low income or low occupational qualification level. Individuals born outside of Sweden had a lower risk. We conclude that surgically treated individuals with a nerve compression disorder have an increased risk of impaired psychological health. Caregivers should be aware of the risk and provide necessary attention.Entities:
Keywords: carpal tunnel surgery; carpal tunnel syndrome; cubital tunnel syndrome; national quality register; nerve compression; psychological health; psychotropic drugs; socioeconomical factors; ulnar nerve entrapment
Year: 2022 PMID: 35807165 PMCID: PMC9267822 DOI: 10.3390/jcm11133871
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Flow chart showing the individuals excluded from the original 2010 Swedish population to obtain the final study sample.
Figure 2Age stratified percentage of use of psychotropic drugs in men and in women, residing in Sweden 2010, and suffering from carpal tunnel syndrome (CTS), ulnar nerve entrapment (UNE) and both disorders as well as in people without any nerve compression disorder.
Characteristics of the 5,751,152 individuals residing in Sweden by 2010 and included in the study sample in relation to the existence of diagnosed and surgically treated carpal tunnel syndrome (CTS), ulnar nerve entrapment (UNE), or both by use of psychotropic drugs as well as demographical and socioeconomic factors. Values are number and percentages (%).
| Nerve Compression Disorders | ||||
|---|---|---|---|---|
| None | CTS | UNE | Both | |
|
| 5,740,385 | 9728 | 890 | 149 |
| (99.81) | (0.17) | (0.02) | (0.00) | |
|
| 1,072,677 | 2,732 | 305 | 53 |
| (18.69) | (28.08) | (34.27) | (35.57) | |
|
| ||||
| 25–34 | 997,168 | 803 | 73 | 6 |
| (17.37) | (8.25) | (8.20) | (4.03) | |
| 35–44 | 1,183,624 | 1689 | 188 | 24 |
| (20.62) | (17.36) | (21.12) | (16.11) | |
| 45–54 | 1,165,714 | 2522 | 260 | 41 |
| (20.31) | (25.93) | (29.21) | (27.52) | |
| 55–64 | 1,147,095 | 2205 | 234 | 41 |
| (19.98) | (22.67) | (26.29) | (32.21) | |
| 65–80 | 1,246,784 | 2509 | 135 | 30 |
| (21.72) | (25.79) | (15.17) | (20.13) | |
|
| 2,865,465 | 3149 | 483 | 63 |
| (49.92) | (32.37) | (54.27) | (42.28) | |
|
| ||||
| Low | 1,309,528 | 2520 | 236 | 31 |
| (22.81) | (25.90) | (26.52) | (20.81) | |
| Middle | 2,038,179 | 3646 | 351 | 57 |
| (35.51) | (37.48) | (39.44) | (38.26) | |
| High | 2,392,678 | 3562 | 303 | 61 |
| (41.68) | (36.62) | (34.04) | (40.94) | |
|
| 778,468 | 1150 | 118 | 24 |
| (13.56) | (11.82) | (13.26) | (16.11) | |
|
| ||||
| Low | 329,645 | 804 | 68 | 15 |
| (5.74) | (8.26) | (7.64) | (10.07) | |
| Middle-low | 2,611,706 | 5469 | 525 | 73 |
| (45.50) | (56.22) | (58.99) | (48.99) | |
| Middle-high | 980,117 | 1300 | 94 | 28 |
| (17.07) | (13.36) | (10.56) | (18.79) | |
| High | 1,267,169 | 1326 | 115 | 18 |
| (22.07) | (13.63) | (12.92) | (12.08) | |
| Missing | 551,748 | 829 | 88 | 15 |
| (9.61) | (8.52) | (9.4889) | (10.07) | |
|
| 1,608,486 | 3993 | 440 | 80 |
| (28.02) | (41.05) | (49.44) | (53.69) | |
Crude (Model 1) and adjusted (Model 2) for demographical and socioeconomic factors association between the existence of diagnosed and surgically treated carpal tunnel syndrome (CTS), ulnar nerve entrapment (UNE), or both and use of psychotropic drugs during the follow-up in the 5,751,152 individuals aged 25–80 residing in Sweden by 2010. Values are prevalence ratios (PR) and 95% confidence intervals (CI).
| Model 1 | Model 2 | |
|---|---|---|
| PR (95% CI) | PR (95% CI) | |
|
| ||
|
None | Ref | Ref |
|
CTS | 1.50 (1.45–1.56) | 1.06 (1.02–1.10) |
|
UNE | 1.83 (1.64–2.05) | 1.16 (1.04–1.29) |
|
Both | 1.90 (1.45–2.49) | 1.08 (0.83–1.42) |
|
| ||
|
25–34 | Ref | |
|
35–44 | 1.12 (1.11–1.13) | |
|
45–54 | 1.20 (1.19–1.21) | |
|
55–64 | 1.30 (1.29–1.31) | |
|
65–80 | 1.49 (1.48–1.50) | |
|
| Ref | |
|
Women | 1.15 (1.15–1.16) | |
|
| ||
|
Low | 1.07 (1.07–1.08) | |
|
Middle | 1.07 (1.06–1.07) | |
|
High | Ref | |
|
| Ref | |
|
Immigrants | 0.89 (0.89–0.90) | |
|
| ||
|
Low | 1.06 (1.05–1.07) | |
|
Middle-low | 1.04 (1.03–1.04) | |
|
Middle-high | 1.00 (1.00–1.01) | |
|
High | Ref | |
|
Missing | 1.27 (1.26–1.42) | |
|
| ||
|
Yes | 15.59 (15.50–15.67) | |
| AUC | 0.501 | 0.885 |
Age stratified unadjusted absolute risk (AR), absolute risk difference (ARD) and 95% confidence intervals (CI) of psychotropic medication use during the follow-up in relation to the existence of diagnosed and surgically treated carpal tunnel syndrome (CTS), ulnar nerve entrapment (UNE), or both in the 5,751,152 individuals aged 25–80 years residing in Sweden by 2010.
| Nerve Compression Disorders | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (Years) | None | CTS | UNE | Both | ||||||||
| N | AR | ARD | N | AR | ARD | N | AR | ARD | N | AR | ARD | |
| 25–34 | 997,168 | 11.09 | Ref. | 803 | 23.66 | 12.57 (9.63–15.51) | 73 | 31.51 | 20.42 (9.76–31.07) | 6 | 16.67 | 5.58 (−24.24–35.40) |
| 35–44 | 1,183,624 | 13.90 | Ref | 1689 | 25.46 | 11.55 (9.48–13.36) | 188 | 31.92 | 18.01 (11.35–24.68) | 24 | 33.33 | 19.43 (0.57–38.29) |
| 45–54 | 1,162,714 | 17.54 | Ref | 2522 | 27.87 | 10.33 (8.25–12.09) | 260 | 40.00 | 22.46 (16.50–28.41) | 41 | 39.02 | 21.48 (6.55–34.42) |
| 55–64 | 1,147,095 | 21.10 | Ref | 2205 | 26.49 | 5.39 (3.54–7.23) | 234 | 29.49 | 8.39 (2.55–14.23) | 48 | 33.33 | 12.24 (−1.10–25.57) |
| 65–80 | 1,246,784 | 28.15 | Ref | 2509 | 32.88 | 4.73 (2.89–6.57) | 135 | 36.30 | 8.15 (0.03–16.26) | 30 | 40.01 | 11.85 (−5.68–29.38) |